Status:

COMPLETED

School-Based Depression Prevention for Adolescents With ADHD

Lead Sponsor:

University of Maryland, College Park

Collaborating Sponsors:

National Institute of Mental Health (NIMH)

Conditions:

Attention Deficit Hyperactivity Disorder

Depressive Symptoms

Eligibility:

All Genders

14-18 years

Phase:

NA

Brief Summary

The purpose of this study is to develop a modified behavioral activation program in adolescents with ADHD to be implemented by school mental health providers in an urban, low-income school district. S...

Detailed Description

Children with ADHD are at elevated risk for depression in adolescence and young adulthood, and this comorbidity is associated with far greater impairment than either disorder alone, including higher r...

Eligibility Criteria

Inclusion

  • Enrolled in a participating Baltimore City Public High School
  • DSM-5 Diagnosis of attention-deficit/hyperactivity disorder (ADHD)
  • Depressive symptoms above T=65 on the Children's Depression Inventory (CDI)

Exclusion

  • History of seizures or neurological problems
  • DSM-diagnosis of Pervasive Developmental Disorder
  • Full scale IQ below 70
  • Current depressive symptoms or active suicidality at severe levels where more intensive services would be warranted

Key Trial Info

Start Date :

August 7 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 11 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04104841

Start Date

August 7 2018

End Date

July 11 2022

Last Update

December 27 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Maryland

College Park, Maryland, United States, 20742